Vascular morbidity and mortality during long-term follow-up in claudicants selected for peripheral bypass surgery

European Journal of Vascular and Endovascular Surgery

Volumn 16, Issue 4, 1998, Pages 292-300

  Dawson, I ^a   Sie, R B ^a   Van der Wall, E E ^a   Brand, R ^a   Van Bockel, J H ^a  

^a IJSSELLAND HOSPITAL   (Netherlands)

Author keywords

Cardiovascular disease; Functional outcome; Infrainguinal bypass; Intermittent claudication; Morbidity; Mortality; Reoperation

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN;

ADULT; AGED; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SMOKING; THROMBOEMBOLISM; TIME; WALKING;

EID: 0031736859     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(98)80048-8     Document Type: Article

References (42)

1. Hertzer NR The natural history of peripheral vascular disease. Implications for its management Circulation 83 1991 I
2. Dormandy JA Mahir M Ascady G Fate of the patient with chronic leg ischaemia. A review article J Cardiovasc Surg (Torino) 30 1989 50 57
3. Gardner AW Poehlman ET Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis JAMA 274 1995 975 980
4. Radack K Wyderski RJ Conservative management of intermittent claudication Ann Intern Med 113 1990 135 146
5. Creasy TS McMillan PJ Fletcher EW Collin J Morris PJ Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial Eur J Vasc Surg 4 1990 135 140
6. Lundgren F Dahllof AG Lundholm K Schersten T Volkmann R Intermittent claudication — surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency Ann Surg 209 1989 346 355
7. Pell JP Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group Eur J Vasc Endovasc Surg 9 1995 469 472
8. Regensteiner JG Steiner JF Hiatt WR Exercise training improves functional status in patients with peripheral arterial disease J Vasc Surg 23 1996 104 115
9. Currie IC Wilson YG Baird RN Lamont PM Treatment of intermittent claudication: the impact on quality of life Eur J Vasc Endovasc Surg 10 1995 356 361
10. Criqui MH Langer RD Fronek A Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
11. Dawson I van Bockel JH Brand R Late non-fatal and fatal cardiac events after infrainguinal bypass for femoropopliteal occlusive disease during a 31-year period J Vasc Surg 18 1993 249 260
12. Farkouh ME Rihal CS Gersh BJ Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery: a population-based study in Olmsted County, Minnesota (1970–1987) J Am Coll Cardiol 24 1994 1290 1296
13. L'Italien GJ Cambria RP Cutler BS Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures J Vasc Surg 21 1995 935 944
14. Kaplan EL Meier P A non-parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
15. Cox DR Regression models and life-tables (with discussion) JR Stat Soc 34(B) 1972 187 220
16. Jonason T Ringqvist I Mortality and morbidity in patients with intermittent claudication in relation to the location of the occlusive atherosclerosis in the leg Angiology 36 1985 310 314
17. Wilson S Wolf GL Cross AP Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients J Vasc Surg 9 1989 1 9
18. McAllister FF The fate of patients with intermittent claudication managed non-operatively Am J Surg 132 1976 593 595
19. Donaldson MC Mannick JA Femoropopliteal bypass grafting for intermittent claudication: is pessimism warranted? Arch Surg 115 1980 724 727
20. Jukema JW Bruschke AVG van Boven AJ Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS) Circulation 91 1994 2528 2540
21. Sacks FM Pfeffer MA Moye LA The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators N Engl J Med 335 1996 1001 1009
22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
23. Kannel WB The demographics of claudication and the aging of the American population Vasc Med Review 1 1996 60 64
24. Prevention of atherosclerotic complications: controlled trial of ketanserin. Prevention of Atherosclerotic Complications with Ketanserin Trial Group Br Med J 298 1989 424 430
25. Hankey GJ Slattery JM Warlow CP The prognosis of hospital-referred transient ischaemic attacks J Neurol Neurosurg Psychiatry 54 1991 793 802
26. Dawson I van Bockel JH Ferrari MD van der Meer FJ Brand R Terpstra JL Ischemic and hemorrhagic stroke in patients on oral anticoagulants after reconstruction for chronic lower limb ischemia Stroke 24 1993 1655 1663
27. Howell MA Colgan MP Seeger RW Ramsey DE Summer DS Relationship of severity of lower-limb peripheral vascular disease to mortality and morbidity: a 6-year follow-up study J Vasc Surg 9 1989 691 696
28. Harris PL Vein graft surveillance — all part of the service Br J Surg 79 1992 97 98
29. Wright MP Davies AH McGrath C Lamont PM Baird RN Late reoperation in vascular surgery Eur J Vasc Endovasc Surg 10 1995 304 307
30. Troëng T Bergqvist D Janson L Incidence and causes of adverse outcomes of operation for chronic ischaemia of the leg Eur J Surg 160 1994 17 25
31. Fry WJ Who sets the standards? J Vasc Surg 13 1991 6 8
32. Zannetti S L'Italien GJ Cambria RP Functional outcome after surgical treatment for intermittent claudication J Vasc Surg 24 1996 65 73
33. Cronenwett JL Intermittent claudication. Current results of non-operative management Arch Surg 119 1984 430 436
34. McDaniel MD Cronenwett JL Basic data related to the natural history of intermittent claudication Ann Vasc Surg 3 1989 273 277
35. Whittemore AD Optimal treatment of intermittent claudication: role of conservative measures, drugs, angioplasty, atherectomy, and operation Veith FJ Current Critical Problems in Vascular Surgery 1996 Quality Medical Publishing, Inc. St. Louis 266 270
36. Kallero KS Bergqvist D Cederholm C Jonsson K Olsson PO Takolander RJ Late mortality and morbidity after arterial reconstruction: the influence of arteriosclerosis in popliteal artery trifurcation J Vasc Surg 2 1985 541 546
37. O'Riordain DS O'Donnell JA Realistic expectations for the patient with intermittent claudication Br J Surg 78 1991 861 863
38. Hughson WG Mann JI Tibbs DJ Woods HF Walton I Intermittent claudication: factors determining outcome Br Med J 1 1978 1377 1379
39. Reunanen A Takkunen H Aromaa A Prevalence of intermittent claudication and its effect on mortality Acta Med Scand 211 1982 249 256
40. Jonason T Bergstrom R Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality Acta Med Scand 221 1987 253 260
41. Conte MS Belkin M Donaldson MC Baum P Mannick JA Whittemore AD Femorotibial bypass for claudication: do results justify an aggressive approach? J Vasc Surg 21 1995 873 881
42. Kent KC Donaldson MC Attinger CE Couch NP Mannick JA Whittemore AD Femoropopliteal reconstruction for claudication. The risk to life and limb Arch Surg 123 1988 1196 1198